US Patent Issued to Eli Lilly and Co. on Jan. 20 for "Anti-human-IL-1-Betaantibodies, encoding nucleic acids thereof and methods of using thereof to treat inflammatory diseases and cancer" (California Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,861, issued on Jan. 20, was assigned to Eli Lilly and Co. (Indianapolis).

"Anti-human-IL-1-Betaantibodies, encoding nucleic acids thereof and methods of using thereof to treat inflammatory diseases and cancer" was invented by Wendy Loza Hobbs (San Diego) and Andrew Dixon Skora (Solana Beach, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides human engineered IL-1 beta antibodies, cells and vectors comprising DNA encoding the same, and methods for producing the antibodies. In addition, the present disclosure provides the use of the human engineered IL-1 beta antibodies for the treatment of inflammatory diseases such...